Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76 | 24 | 100 | 37 | 13 |
| Receivables | 8 | 7 | 244 | 15 | 67 |
| Inventories | 70 | 40 | 48 | 139 | 132 |
| TOTAL | $234 | $128 | $437 | $226 | $244 |
| Non-Current Assets | |||||
| PPE Net | 18 | 33 | 43 | 62 | 36 |
| Intangibles | 187 | 233 | 343 | 344 | 183 |
| Other Non-Current Assets | 0 | 55 | 47 | 0 | 0 |
| TOTAL | $205 | $320 | $433 | $406 | $219 |
| Total Assets | $439 | $449 | $871 | $631 | $463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 58 | 16 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,360 | 961 | 553 | 1,158 | 655 |
| TOTAL | $2,106 | $1,240 | $987 | $1,581 | $1,109 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 300 | 0 | 0 | 0 | 0 |
| TOTAL | $300 | $N/A | $N/A | $N/A | $2 |
| Total Liabilities | $2,406 | $1,240 | $987 | $1,581 | $1,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,661 | 28,135 | 16,709 | 8,298 | 7,445 |
| Common Shares | 28 | 28 | 16 | 8 | 7 |
| Retained earnings | -14,473 | -13,077 | -10,817 | -8,520 | -5,328 |
| Other shareholders' equity | -9 | -52 | -86 | -232 | -444 |
| TOTAL | $-1,967 | $-791 | $-117 | $-950 | $-648 |
| Total Liabilities And Equity | $439 | $449 | $871 | $631 | $463 |